Stay updated with breaking news from Rak Choi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease.
A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease. Researchers led by Ankit A. Desai, MD, associate professor of medicine at the Krannert Cardiovascular Research Center (KCVRC) at Indiana University School of Medicine, have been awarded a $3 million grant by the U.S. Department of Defense to evaluate the efficacy of this drug.
In its fourth year, Brown Biomedical Innovations to Impact is advancing the commercialization of Brown research and supporting the creation of new products aimed at saving and improving lives.